TrialJournal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer2025

Lenvatinib Plus Pembrolizumab, Pemetrexed, and a Platinum as First-Line Therapy for Metastatic Nonsquamous NSCLC: Phase 3 LEAP-006 Study.

Roy S Herbst et al.PubMed ↗Publisher ↗

No numbers read from the abstract.